CDC holds off on easing COVID guidelines for senior living communities … Genesis HealthCare announces millionth point-of-care COVID-19 test … Men may have higher odds of Parkinson’s if they sleepwalk...
Active lifestyle may slow cognitive decline in people with Parkinson’s and dementia gene: study
By
Alicia Lasek
Apr 02, 2021
Greater physical activity at the study’s start appeared to lessen gene-related cognitive decline two years later, the authors report.
Parkinson’s Foundation expands free, at-home genetic testing initiative
By
Alicia Lasek (f3)
May 06, 2022
The organization is making an effort to connect a broader and more diverse set of candidates to clinical trials.
Clinical briefs for Monday, June 14
By
Alicia Lasek
Jun 14, 2021
3 FDA advisory panel members resign in wake of controversial approval of new Alzheimer’s drug … U.S. suspends COVID J&J vaccine shipments as backlog builds; extends expiration dates … VoiceFriend...
Start-up gains FDA clearance to track Parkinson’s symptoms using Apple Watch
By
Alicia Lasek (f3)
Jun 15, 2022
Clinicians can use the data provided by StrivePD software via Apple Watch to help Parkinson’s patients manage their symptoms, its developer says.
Clinical briefs for Thursday, July 20
By
Kristen Fischer
Jul 20, 2023
The gene mutation that explains asymptomatic COVID-19 … New discovery sheds light on familial Parkinson’s disease … Parkinson’s can go incognito more than a decade before symptoms
Clinical briefs for Friday, March 5
By
Alicia Lasek
Mar 05, 2021
B117 variant of SARS-CoV-2 up to 90% more transmissible; UK experts urge vigilance … Early evidence suggests smoking cessation drug may treat Parkinson’s … Scream, not swab: Dutch inventor hopes...
Clinical Briefs for Friday, April 3
By
Alicia Lasek
Apr 02, 2020
Phone-based therapy beneficial for depression in Parkinson’s disease … Sending COVID-19-positive residents to hospital may be wrong ‘knee-jerk’ reaction … CDC releases COVID-19 infection...
Clinical briefs for Tuesday, April 6
By
Alicia Lasek
Apr 06, 2021
COVID outbreak among vaccinated assisted living residents under investigation … FDA rejects bid to approve Nuplazid for treatment of dementia-related psychosis … J&J betting $780M on long-acting antiviral...